About this trial
The goal of this clinical trial is to learn if a novel device (MindfulGarden) is beneficial in a population of patients undergoing cardiac surgery. The main questions it aims to answer are:
Is a novel device (MindfulGarden) that uses responsive nature-driven imagery feasible in patients undergoing cardiac surgery? Will use of this device reduce the use of psychotropic medications, improve recovery experience, and improve delirium?
Participants will receive routine post-operative management and standard delirium reduction measures. They will be randomized into two groups where one receives the novel device (MindfulGarden) and the other does not.
Eligibility criteria
Qualifiers
Planned open-heart cardiac surgery (e.g. coronary artery bypass grafting, valve replacement surgery);
Able to understand study procedures and provide informed consent in English;
At least one delirium risk factor: 1) Age less than 65yrs; 2) History of delirium; 3) History of stroke/TIA; 4) Known cognitive impairment; 5) Depression requiring medication.
Disqualifiers
Severe pre-existing cognitive impairment (Montreal Cognitive Assessment [MOCA6]<10)
Uncorrected visual impairment;
Significant impairment from psychiatric disease;
Enrolment in another clinical trial which may interfere with the study outcome measures.
Trial design
Treatments tested in this trial
- A novel device developed providing nature-driven responsive imagery that responds to the patient's physiological to distract, engage, and de-escalate behaviours of delirium.
- Routine post-operative management and standard delirium reduction measures.
Treatment groups
Sponsors and collaborators
University of British Columbia
Lead sponsor
Canadian Anesthesiologists' Society
Collaborator